Palliation double stenting for malignant biliary and duodenal obstruction
- Authors:
- Liang Zhao
- Haitao Xu
- Yubao Zhang
View Affiliations
Affiliations: Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China
- Published online on: November 18, 2015 https://doi.org/10.3892/etm.2015.2875
-
Pages:
348-352
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The surgical management of patients with malignant biliary and duodenal obstruction is complex. Tumor excision is no longer possible in the majority of patients with malignant obstructive jaundice and duodenal obstruction. The aim of the present study was to evaluate the effectiveness of intraluminal dual stent placement in malignant biliary and duodenal obstruction. In total, 20 patients with malignant obstructive jaundice and duodenal obstruction, including 6 with pancreatic carcinoma, 11 with cholangiocarcinoma, 1 with duodenal carcinoma and 2 with abdominal lymph node metastasis, were treated with intraluminal stent placement. Bile duct obstruction with late occurrence of duodenal obstruction was observed in 16 cases, and duodenal obstruction followed by a late occurrence of bile duct obstruction was observed in 3 cases, while, in 1 case, bile duct obstruction and duodenal obstruction occurred simultaneously. After X‑ray fluoroscopy revealed obstruction in the bile duct and duodenum, stents were placed into the respective lumens. Percutaneous transhepatic placement was employed for the biliary stent, while the duodenal stent was placed perioraly. The clinical outcomes, including complications associated with the procedures and patency of the stents, were evaluated. The biliary and duodenal stents were successfully implanted in 18 patients and the technical success rate was 90% (18/20). A total of 39 stents were implanted in 20 patients. In 2 cases, duodenal stent placement failed following biliary stent placement. Duodenal obstruction remitted in 15 patients, and 1 patient succumbed to aspiration pneumonia 5 days after the procedure. No severe complications were observed in any other patient. The survival time of the 18 patients was 5‑21 months (median, 9.6 months), and 6 of those patients survived for >12 months. The present study suggests that X‑ray fluoroscopy‑guided intraluminal stent implantation is an effective procedure for the treatment of malignant biliary and duodenal obstruction.
View References
|
1
|
de Baere T, Harry G, Ducreux M, Elias D,
Briquet R, Kuoch V and Roche A: Self-expanding metallic stents as
palliative treatment of malignant gastroduodenal stenosis. AJR Am J
Roentgenol. 169:1079–1083. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pinto IT: Malignant gastric and duodenal
stenosis: Palliation by peroral implantation of a self-expanding
metallic stent. Cardiovasc Intervent Radiol. 20:431–434. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee BH, Choe DH, Lee JH, Kim KH and Chin
SY: Metallic stents in malignant biliary obstruction: Prospective
long-term clinical results. AJR Am J Roentgenol. 168:741–745. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yasumoto T, Yokoyama S and Nagaike K:
Percutaneous transcholecystic metallic stent placement for
malignant obstruction of the common bile duct: Preliminary clinical
evaluation. J Vasc Interv Radiol. 21:252–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung GS, Song HY, Kang SG, Huh JD, Park
SJ, Koo JY and Cho YD: Malignant gastroduodenal obstructions:
Treatment by means of a covered expandable metallic stent-initial
experience. Radiology. 216:758–763. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oikarinen H, Leinonen S, Karttunen A,
Tikkakoski T, Hetemaa T, Mäkelä J and Päivänsalo M: Patency and
complications of percutaneously inserted metallic stents in
malignant biliary obstruction. J Vasc Interv Radiol. 10:1387–1393.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaw M, Singh S and Gagneja H: Clinical
outcome of simultaneous self-expandable metal stents for palliation
of malignant biliary and duodenal obstruction. Surg Endosc.
17:457–461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim KO, Kim TN and Lee HC: Effectiveness
of combined biliary and duodenal stenting in patients with
malignant biliary and duodenal obstruction. Scand J Gastroenterol.
47:962–967. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maire F, Hammel P, Ponsot P, Aubert A,
O'Toole D, Hentic O, Levy P and Ruszniewski P: Long-term outcome of
biliary and duodenal stents in palliative treatment of patients
with unresectable adenocarcinoma of the head of pancreas. Am J
Gastroenterol. 101:735–742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Profili S, Feo CF, Meloni GB, Strusi G,
Cossu ML and Canalis GC: Combined biliary and duodenal stenting for
palliation of pancreatic cancer. Scand J Gastroenterol.
38:1099–1102. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akinci D, Akhan O, Ozkan F, Ciftci T,
Ozkan OS, Karcaaltincaba M and Ozmen MN: Palliation of malignant
biliary and duodenal obstruction with combined metallic stenting.
Cardiovasc Intervent Radiol. 30:1173–1177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tonozuka R, Itoi T, Sofuni A, Itokawa F
and Moriyasu F: Endoscopic double stenting for the treatment of
malignant biliary and duodenal obstruction due to pancreatic
cancer. Dig Endosc. 25(Suppl 2): 100–108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Katsinelos P, Kountouras J, Germanidis G,
Paroutoglou G, Paikos D, Lazaraki G, Pilpilidis I, Chatzimavroudis
G, Fasoulas K and Zavos C: Sequential or simultaneous placement of
self-expandable metallic stents for palliation of malignant biliary
and duodenal obstruction due to unresectable pancreatic head
carcinoma. Surg Laparosc Endosc Percutan Tech. 20:410–415. 2010.
View Article : Google Scholar : PubMed/NCBI
|
